SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-22-007628
Filing Date
2022-07-11
Accepted
2022-07-11 16:30:35
Documents
1
Period of Report
2022-07-08

Document Format Files

Seq Description Document Type Size
1 form4a-07112022_040717.html 4/A  
1 form4a-07112022_040717.xml 4/A 6620
  Complete submission text file 0001415889-22-007628.txt   8005
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
SULLIVAN LOUIS W (Reporting) CIK: 0001193522 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-26301 | Film No.: 221077242